
Loading, please wait...

Loading, please wait...

The Ministry of Health recently reported that C-section rates in India have witnessed a staggering four-fold rise over the last sixteen years. Specifically, surgical deliveries now account for over 27 per cent of all reported births in the 2024-25 period. This data highlights a consistent year-on-year increase from 12.03 lakh to over 54.35 lakh. Notably, the share first crossed the 10 per cent threshold in 2012-13 and surpassed 20 per cent by 2020-21. By 2024-25, the figure rose further to 27.46 per cent.
A study by the Population Research Centre identified several clinical factors for this shift. For instance, advanced maternal age and multiple pregnancies often necessitate surgical intervention. Additionally, fetal distress and previous C-sections significantly increase the likelihood of another surgery. However, the study also suggests that changing patient preferences influence doctors' decision-making processes. Consequently, medical practitioners must balance clinical necessity with patient safety to ensure optimal outcomes for both mother and child.
To address unnecessary surgeries, the government has implemented several monitoring protocols. Hospitals empanelled under CGHS must now display their ratio of surgical to normal deliveries. Furthermore, the 'LaQshya' initiative includes a dedicated audit component for maternity operation theatres. The health ministry also conducts training programs like 'Daksh' and 'Dakshta' to promote natural birth skills. Despite the rise in surgeries, India has seen a sharp decline in maternal mortality. For example, the Maternal Mortality Ratio dropped from 212 to 88 per lakh live births. Likewise, the Infant Mortality Rate has decreased from 57 to 25 per thousand live births.
Q1: Why are C-sections increasing in India?
Clinical factors such as advanced maternal age, fetal distress, and prior surgeries contribute to the rise. Furthermore, changing patient preferences and clinical decision-making also play significant roles in the increasing trend.
Q2: How does the government regulate unnecessary C-sections?
The government monitors these trends through the LaQshya initiative audits. Additionally, CGHS-empanelled hospitals must publicly display their C-section to normal delivery ratios to ensure transparency.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


India's C-section rates jumped from 12 lakh to 54 lakh between 2008 and 2025, now accounting for 27.46% of births. Learn about the causes and regulations....
7 months ago

Review how tailored exercise programs benefit frail older patients with heart failure. Explore pathophysiological mechanisms, individualized training prescriptions, and strategies to overcome adherence barriers in clinical practice.
Today

Leucine Rich Bio has introduced South Asia's first comprehensive vaginal microbiome test, BugSpeaks. By profiling microbial dysbiosis, pathogens, and antimicrobial resistance, this next-generation diagnostic platform provides clinicians with deeper insights into recurrent infections, fertility, and reproductive health.
Today

In high-risk pulmonary embolism complicated by severe anemia and active uterine bleeding, systemic thrombolysis is contraindicated. Large-bore aspiration thrombectomy provides rapid hemodynamic rescue without fibrinolysis, supported by inferior vena cava filter placement and multidisciplinary critical care.
Today

This comparative study evaluates posterior labral tears with and without glenohumeral instability, highlighting distinct demographic patterns, MRI underestimation in stable shoulders, and successful arthroscopic repair outcomes.
Today

A clinical study demonstrates that early intervention with tocilizumab, either as monotherapy or bridged with corticosteroids, achieves significant proptosis reduction and resolves active inflammation in treatment-naive thyroid eye disease.
Today